zithromax has been researched along with Corneal-Ulcer* in 6 studies
6 other study(ies) available for zithromax and Corneal-Ulcer
Article | Year |
---|---|
Successful management of pediatric pythium insidiosum keratitis with cyanoacrylate glue, linezolid, and azithromycin: Rare case report.
Pythium insidiosum causes a rare sight-threatening keratitis and is a devastating ocular pathology with a high morbidity. It is frequently mistaken as fungal keratitis. Here we highlight a rare case of pediatric Pythium insidiosum keratitis which was successfully managed using an antibiotic combination of linezolid and azithromycin with cyanoacrylate glue.. A 9-year-old young male child presented to our clinic with defective vision, pain, redness in the right eye for 5 days post stick injury. In the right eye, Snellen's best-corrected visual acuity (BCVA) was 6/12 which deteriorated to hand movements within 5 days of treatment. Ocular examination revealed 6 × 5 mm dry-looking mid stromal corneal infiltrate with feathery margin involving the visual axis. The clinical picture was suggestive of fungal keratitis. Corneal scraping and smear examination with 10% KOH and Gram stain revealed long slender hyaline hyphae with sparse septations. Before the culture result, the patient was started on 5% Natamycin and 1% Itraconazole hourly, but still, the infiltrate progressed. Further, P. Insidiosum keratitis was considered as the differential, which was confirmed on blood agar culture. After receiving culture results, the patient was managed with 0.2% Linezolid and 1% Azithromycin hourly. Due to the rapid progression of infiltrate, corneal melt, and younger age, cyanoacrylate glue, and bandage contact lens were used. On the last follow-up, the BCVA recovered to 6/12.. Prompt diagnosis, clinical awareness, and a specific treatment regime is needed for managing this devastating corneal entity. Cyanoacrylate glue due to its antibacterial properties can be a potential rescuer and can be considered for managing these cases. Topics: Animals; Anti-Bacterial Agents; Azithromycin; Child; Corneal Ulcer; Cyanoacrylates; Eye Infections, Fungal; Humans; Keratitis; Linezolid; Male; Pythiosis; Pythium | 2022 |
Anterior segment optical coherence tomography imaging in peripheral ulcerative keratitis, a corneal structural description.
Anterior segment optical coherence tomography (AS OCT) is a helpful tool used to diagnose and manage many corneal conditions, but its use has not been reported in case of peripheral ulcerative keratitis (PUK). The aim of this study is to describe AS OCT findings in cases of PUK.. Retrospective observational case series of six eyes presenting with a PUK and proven systemic vasculitis. Clinical course, slit lamp photographs, and AS OCT findings were the main outcomes.. The AS OCT findings were found to correlate with the ocular disease's level of activity. In the acute stage, an absence of corneal epithelium, a scrambled appearance of the anterior stroma and a heterogeneous stromal reflectivity were observed. During the reduction of disease level activity, an irregular hyporeflective epithelium, a smoother anterior stroma, and a homogenous hyperreflective stroma were seen. At the healed stage, a filling of the corneal defect by a hyporeflective thick epithelium, the persistence of the hyperreflective underlying stroma, and a demarcation line were observed. The mean total corneal thickness at last follow-up was significantly thicker (509 ± 147 μm) compared with the mean corneal thickness at onset (408 ± 131 μm; P = 0.03).. AS OCT provides an assessment of structural changes occurring in PUK, useful for its diagnosis and monitoring. Topics: Adult; Aged; Anterior Eye Segment; Anti-Bacterial Agents; Azithromycin; Corneal Stroma; Corneal Ulcer; Drug Therapy, Combination; Epithelium, Corneal; Female; Follow-Up Studies; Glucocorticoids; Humans; Immunosuppressive Agents; Male; Methylprednisolone; Middle Aged; Retrospective Studies; Slit Lamp Microscopy; Tomography, Optical Coherence | 2020 |
Clinical profile, risk factors and outcome of medical, surgical and adjunct interventions in patients with
To report clinical profile and compare management options for Pythium keratitis.. Retrospective interventional study of 46 patients diagnosed as Pythium keratitis by PCR DNA sequencing from January 2014 to July 2017. Interventions were categorised into medical management (MM) (topical azithromycin and linezolid with oral azithromycin at presentation), surgery (S) (therapeutic penetrating keratoplasty, TPK), surgical adjunct (SA) (cryotherapy±alcohol with TPK) and medical adjunct (MA) (MM after TPK).. Primary treatment included MM (1 eye), SA (3 eyes) and S (42 eyes). Recurrence occurred in 27/43 eyes (MM+S group). Second surgery (S) was required in 11 eyes (TPK-2), with additional procedures (SA) in 10 eyes and evisceration in five eyes. 8/43 eyes received MA after TPK-1. One eye required TPK-3. Recurrence occured in all eyes that received MA (100%) and in 28 of 54 TPKs (51.8%) (TPK 1+2+3) in 42 eyes. Recurrence was noted in 1/14 (7.1%) that underwent SA.. The currently available and recommended treatment for Pythium keratitis is surgical by means of a TPK and in worse cases evisceration. In our study, MM/MA measures showed no benefit with recurrence or worsening of infection requiring resurgery. Almost 50% of TPKs had a recurrence requiring resurgery. However, adjunctive procedures during TPK appear to have additional benefit with low risk of recurrence and could be included as routine care. Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Azithromycin; Child; Corneal Ulcer; DNA, Protozoan; Eye Infections, Parasitic; Female; Humans; Keratoplasty, Penetrating; Linezolid; Male; Middle Aged; Polymerase Chain Reaction; Pythiosis; Pythium; Retrospective Studies; Risk Factors; Treatment Outcome | 2019 |
Azithromycin in the Management of Pythium insidiosum Keratitis.
Topics: Azithromycin; Child; Corneal Ulcer; Eye Infections, Fungal; Humans; Male; Pythiosis; Pythium; Treatment Outcome | 2018 |
In vitro transcorneal diffusion of the antimicrobial macrolides azithromycin and clarithromycin and the impact on microbial keratitis.
To compare the in vitro penetration of azithromycin and clarithromycin across both human and rabbit corneas.. In vitro diffusion studies were performed on frozen-thawed (liquid nitrogen, -80 degrees C) corneas using a flow-through diffusion apparatus (24 hours, 20 degrees C, 1.5 mL/h). Either phosphate-buffered saline (PBS) or 2 mg/g polyacrylic acid (Teargel) formulations of clarithromycin and azithromycin (1 or 4 mg/mL) were used in the donor chambers. Effluent samples collected (2 hours) were analyzed using binary high-performance liquid chromatography in conjunction with either UV/VIS or tandem mass spectrometry detection.. The flux values of azithromycin (PBS and polyacrylic acid) across both types of corneas showed concentration dependence. Polyacrylic acid formulations showed a decrease in flux values of azithromycin across both types of corneas. For clarithromycin, flux values across both types of corneas were approximately 2.3-2.4 times higher than azithromycin. The flux values of azithromycin at 4 mg/mL (PBS and polyacrylic acid) across human cornea were higher than those across rabbit cornea, whereas the inverse was true at 1 mg/mL PBS for both drugs.. Both macrolides penetrated the corneas, and the flux values were found to be concentration dependent (azithromycin). Clarithromycin had a higher diffusion rate across corneas than azithromycin. Although the human cornea had a higher permeability to azithromycin at a higher concentration, the inverse was found at lower concentrations for both drugs. Rabbit cornea can be used in general as an in vitro permeability model for human cornea; however, care must be taken with the extrapolation of results. Topics: Adult; Aged; Animals; Anti-Bacterial Agents; Azithromycin; Chromatography, High Pressure Liquid; Clarithromycin; Cornea; Corneal Ulcer; Diffusion; Eye Infections, Bacterial; Humans; Middle Aged; Permeability; Rabbits; Tandem Mass Spectrometry; Young Adult | 2009 |
Ocular therapeutics.
Topics: Adenoviridae Infections; Administration, Topical; Anti-Bacterial Agents; Azithromycin; Bacterial Infections; Clinical Trials, Phase I as Topic; Conjunctivitis; Corneal Ulcer; Dexamethasone; Diagnostic Techniques, Ophthalmological; Drug Combinations; Drug Delivery Systems; Eye Diseases; Glucocorticoids; Humans; Phenytoin; Sclera; United States; United States Food and Drug Administration | 2007 |